» Articles » PMID: 3662472

In Vitro Susceptibility of Coxiella Burnetii to Antibiotics, Including Several Quinolones

Overview
Specialty Pharmacology
Date 1987 Jul 1
PMID 3662472
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Antibiotic susceptibility testing of the rickettsial Q fever agent Coxiella burnetii was performed by using persistently infected L929 fibroblast cells. The efficacies of a variety of antibiotics with different metabolic targets were tested and compared. The most effective antibiotics in bringing about the elimination of the parasite from infected cells included several quinolone compounds and rifampin. Of the quinolone compounds tested, difloxacin (A-56619) was the most effective, followed by ciprofloxacin and oxolinic acid. These three quinolones were apparently rickettsiacidal. After 48 h of exposure to microgram amounts of the compounds (ranging from 2 micrograms of difloxacin per ml to 5 micrograms of the other two antibiotics per ml), the number of intracellular parasites markedly declined; after 10 days of treatment, very few intracellular rickettsiae were detected. Rifampin (1 microgram/ml) was also very effective in eliminating the parasites. Some of the 13 other antibiotics tested that were somewhat effective included chloramphenicol, doxycycline, and trimethoprim. The persistently infected L929 cells were found to provide a convenient system for the relatively rapid determination of the susceptibility of C. burnetii to antibiotics.

Citing Articles

Comparison of Paired Immunofluorescent Antibody Serology and Real-Time Polymerase Chain Reaction Testing for the Detection of Acute Q Fever among Febrile Patients in Kilimanjaro, Tanzania, 2012-2014.

Rolfe R, Crump J, Maro V, Mmbaga B, Saganda W, Lwezaula B Am J Trop Med Hyg. 2025; 112(3):533-538.

PMID: 39742524 PMC: 11884282. DOI: 10.4269/ajtmh.23-0860.


Evaluation of Novel HLM Peptide Activity and Toxicity against Planktonic and Biofilm Bacteria: Comparison to Standard Antibiotics.

Masadeh M, Alshogran H, Alsaggar M, Sabi S, Al Momany E, Masadeh M Curr Protein Pept Sci. 2024; 25(10):826-843.

PMID: 38910428 DOI: 10.2174/0113892037291252240528110516.


Efficacy of rifapentine and other rifamycins against .

Miller H, Kersh G Microbiol Spectr. 2024; 12(7):e0103424.

PMID: 38864598 PMC: 11218529. DOI: 10.1128/spectrum.01034-24.


A global overview of the most important zoonotic bacteria pathogens transmitted from to humans in urban environments.

Sabour S, Azimi T, Nasser A, Hadi N, Mohsenzadeh A, Shariati A Infect Med (Beijing). 2023; 1(3):192-207.

PMID: 38077628 PMC: 10699683. DOI: 10.1016/j.imj.2022.07.002.


Intracellular Activity of Antibiotics against Coxiella burnetii in a Model of Activated Human THP-1 Cells.

Peyrusson F, Whelan A, Hartley M, Norville I, Harding S, Van Bambeke F Antimicrob Agents Chemother. 2021; 65(12):e0106121.

PMID: 34543094 PMC: 8597764. DOI: 10.1128/AAC.01061-21.


References
1.
Varma M, Adgey A, Connolly J . Chronic Q fever endocarditis. Br Heart J. 1980; 43(6):695-9. PMC: 482771. DOI: 10.1136/hrt.43.6.695. View

2.
PIERCE M, Saag M, Dismukes W, Cobbs C . Q fever endocarditis. Am J Med Sci. 1986; 292(2):104-6. DOI: 10.1097/00000441-198608000-00007. View

3.
Roman M, Coriz P, Baca O . A proposed model to explain persistent infection of host cells with Coxiella burnetii. J Gen Microbiol. 1986; 132(5):1415-22. DOI: 10.1099/00221287-132-5-1415. View

4.
Baca O, Akporiaye E, Aragon A, Martinez I, Robles M, Warner N . Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines. Infect Immun. 1981; 33(1):258-66. PMC: 350684. DOI: 10.1128/iai.33.1.258-266.1981. View

5.
Akporiaye E, Baca O . Superoxide anion production and superoxide dismutase and catalase activities in Coxiella burnetii. J Bacteriol. 1983; 154(1):520-3. PMC: 217490. DOI: 10.1128/jb.154.1.520-523.1983. View